Genmab A/S (NASDAQ:GMAB) Q1 2024 Earnings Call Transcript
Genmab A/S reports earnings inline with expectations. Reported EPS is $0.16 EPS, expectations were $0.16.
Genmab A/S (GMAB)
Market is closed
News
- First
- << Previous
- 11 - 20
- Next >>
30 Biggest Biotechnology Companies in the World
In this article, we will be taking a look at the 30 biggest biotechnology companies in the world.
Genmab A/S (NASDAQ:GMAB) Q4 2023 Earnings Call Transcript
Genmab A/S misses on earnings expectations. Reported EPS is $0.14 EPS, expectations were $0.35.
12 High Growth International Stocks to Buy
In this article, we discuss the 12 high growth international stocks to buy.
Genmab A/S (NASDAQ:GMAB) Q3 2023 Earnings Call Transcript
Operator: Hello, and welcome to Genmab's Third Quarter 2023 Financial Results Conference Call. As a reminder, this conference call is being recorded.
Genmab A/S (NASDAQ:GMAB) Q2 2023 Earnings Call Transcript
Operator: Hello, and welcome to Genmab's Second Quarter 2023 Financial Results Conference Call. As a reminder, this conference call is being recorded.
Genmab A/S (NASDAQ:GMAB) Q1 2023 Earnings Call Transcript
Operator: Hello, and welcome to the Genmab's First Quarter 2023 Financial Results Conference Call. As a reminder, this conference call is being recorded.
15 Most Profitable Growth Stocks Now
Growth stocks refer to listed companies that are growing their profits, revenue, or cash flow at a rate that exceeds their competitors and beats the overall market.
5 High Growth International Stocks to Buy
SolarEdge Technologies, Inc. (NASDAQ:SEDG) was incorporated in 2006 and is headquartered in Herzliya, Israel.
- First
- << Previous
- 11 - 20
- Next >>
Billionaire Hedge Funds
